Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Acta Dermatovenerol Croat ; 19(4): 255-63, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22185926

RESUMO

Epidermolysis bullosa is a group of inherited diseases that are characterized by skin and mucosal fragility and blister formation. A wide variety of extracutaneous manifestations can develop as well as various complications of the disease such as severe anemia, growth retardation, esophageal stenosis, mutilating deformities of hands and feet, glomerulonephritis leading to chronic renal failure, and many others. One of the most important and often occurring complications is the development of cutaneous squamous cell carcinomas that grow and metastasize quickly. The objective of this paper is to give dermatologists a review of major complications encountered in patients with epidermolysis bullosa. Since these complications occur so often and can be considered to be part of the clinical picture, it is mandatory to develop a multidisciplinary well-educated team involved in follow-up and treatment of these patients.


Assuntos
Epidermólise Bolhosa/complicações , Anemia/etiologia , Carcinoma de Células Escamosas/etiologia , Criança , Doença Crônica , Epidermólise Bolhosa/genética , Epidermólise Bolhosa/fisiopatologia , Gastroenteropatias/etiologia , Deformidades da Mão/etiologia , Humanos , Neoplasias/etiologia , Osteoporose/etiologia , Neoplasias Cutâneas/etiologia
3.
Lijec Vjesn ; 133(11-12): 376-84, 2011.
Artigo em Servo-Croata (Latino) | MEDLINE | ID: mdl-22329293

RESUMO

Langerhans' cell histiocytosis (LCH) is a disease characterised by pathologic accumulation and proliferation of histiocytes, cells from the monocyte-macrophage system, in various tissues and organs. In this retrospective study we analyzed patients charts treated in the Department of pediatric hematology and oncology at the University Hospital Zagreb with the diagnosis of LCH. Twenty-two children were diagnosed between January 1st 1996 and December 31st 2010, and all were treated with chemotherapy. 19 patients survived (86%) and the remaining 3 (14%), all under the age of 2 with multisystem disease, died. At the time of diagnosis 12 children (55%) presented with single-system disease, the most common were bone lesions in 8 children (36%). All children were treated according to protocols LCH-I and LCH -III. Eight children had mild complications of treatment and the disease itself. Diabetes insipidus remains in 4 children.


Assuntos
Histiocitose de Células de Langerhans/tratamento farmacológico , Criança , Pré-Escolar , Feminino , Histiocitose de Células de Langerhans/diagnóstico , Histiocitose de Células de Langerhans/patologia , Humanos , Lactente , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA